LaVoieHealthScience

What LaVoieHealthScience does

LaVoieHealthScience is the healthcare and life sciences division of LaVoie Strategic Communications Group, Inc., a privately held, woman-owned strategic communications firm founded in 2000 and headquartered in Boston, Massachusetts. The firm delivers integrated strategic communications, public relations, investor relations, marketing, crisis communications, digital/creative services, and event support to three principal client segments: commercial healthcare leaders (pharma, biotech, medical technology), government and public health organizations (via the sibling LaVoieGov division), and emerging biotech innovators preparing for financing events, regulatory milestones, or commercialization.

The firm's core service portfolio comprises four pillars — Strategic Positioning, PR & Marketing, IR & Corporate Communications, and Digital & Creative — augmented by a registered proprietary methodology called the LHS Fifteen-Slide Presentation®, which is featured at industry events such as BIO 2026. The firm does not sell a software platform; its deliverables are professional services anchored in senior-led account teams, deep regulatory and scientific domain expertise, and a relationship network spanning media, investors, policymakers, advocacy groups, and Key Opinion Leaders. The firm has earned 60+ industry awards and is recognized as a top healthcare communications firm in the US and Massachusetts.

LaVoieHealthScience operates a quote-based professional services model under multi-year enterprise engagements. Pricing is not publicly disclosed; engagements are scoped through direct consultation with senior account leads. The firm has an 11–50 employee footprint, two US office locations (Boston headquarters and Florida), and serves clients globally on a project basis. The firm is independently held, founder-led, and reports no institutional funding, M&A activity, or parent company ownership.

Name

LaVoieHealthScience

Legal name

LaVoie Strategic Communications Group, Inc.

Website

https://lavoiehealthscience.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

LaVoieHealthScience is a Boston-based strategic communications firm delivering PR, investor relations, marketing, crisis, and digital services to commercial healthcare leaders, government/public health agencies, and emerging biotech innovators through senior-led, multi-year enterprise engagements.

Ownership category

akta.pro rank

Product category

Healthcare Communications Services

NAICS

Public Relations Agencies (541820), Advertising, Public Relations, and Related Services (5418)

SIC

Services-Advertising Agencies (7311)

akta.pro primary industry

Healthcare & Life Sciences PR (BPAFADAJ)

akta.pro secondary industries

Healthcare & Life Sciences PR (MPAAADAD), Healthcare/Pharma Creative Agencies (MPAAAAAJ), Public Health Strategy, Policy & Legislation (HLAJAMAA), Community Health, Health Promotion & Behavior Change (SBCC) (BPADAIAL)

Keywords

• Healthcare public relations
• Biotech investor relations
• Life sciences communications
• Crisis communications services
• Strategic communications advisory

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Strategic Communications Services: Professional services revenue from providing strategic communications, public relations, investor relations, marketing, crisis communications, digital communications, research and audience insights, and event planning services to healthcare, biotech, government, and public health clients.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

LaVoieHealthScience is a specialized strategic communications agency that designs and executes integrated public relations, investor relations, marketing, crisis communications, digital/creative, and strategic positioning programs for healthcare, biotech, life sciences, and public sector clients. Services are delivered by senior-led teams that translate complex scientific, regulatory, and clinical milestones into clear narratives for investors, media, policymakers, and other stakeholders.

Product overview

LaVoieHealthScience is a division of LaVoie Strategic Communications Group, a specialized strategic communications and public relations agency serving the biotech, life sciences, and healthcare sectors. The company operates as a services-based firm offering an integrated portfolio of communication services rather than a software platform. Its core service offerings include Strategic Positioning (which aligns communications with business and scientific strategy), PR & Marketing (media relations and campaign execution), IR & Corporate Communications (investor relations and stakeholder engagement), and Digital & Creative services. The company also offers a proprietary methodology called the LHS Fifteen-Slide Presentation for communicating complex science. LaVoie serves three primary client segments: commercial healthcare leaders, government and public health organizations, and emerging innovators. The parent company LaVoie Strategic Communications Group also operates a separate division called LaVoieGov for government and public sector communications.

Differentiator

Problem solved

Functional benefit

Products and services

• Strategic Positioning Strategic communications service that aligns messaging with business, scientific, and organizational strategy, translating complex milestones such as clinical data and regulatory developments into clear narratives for healthcare, biotech, and life sciences stakeholders.
• PR & Marketing Public relations and marketing services including media relations, campaign execution, and brand visibility programs for healthcare, biotech, life sciences, and medical technology organizations.
• IR & Corporate Communications Investor relations and corporate communications services helping healthcare and biotech organizations navigate investor scrutiny, financing events, IPO readiness, and stakeholder engagement.
• Digital & Creative Digital communications and creative services supporting multi-channel engagement, digital presence, visual content creation, and digital marketing programs for healthcare and life sciences clients.
• LHS Fifteen-Slide Presentation® Proprietary registered presentation methodology for biotech leaders to communicate complex science effectively, with sessions offered at major industry events such as BIO.

Quantifiable outcome

• Trusted relationships with media, investors, policymakers, advocacy groups, and KOLs
• +1 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Canale Communications: Specialized life sciences communications agency serving biotech, pharma, and medtech. Direct competitor focused exclusively on healthcare/life sciences PR and IR with similar vertical specialization and senior-led model.
• Makovsky: Independent healthcare PR and communications agency with similar mid-size positioning. Comparable in serving pharma, biotech, and medical device clients with integrated PR, IR, and corporate communications services.
• Real Chemistry: Large healthcare-focused communications, marketing, and data science agency (formerly W2O Group). Direct competitor serving the same pharma/biotech client base with integrated PR, IR, and digital services at significantly greater scale.
• PAN Communications: Mid-size integrated marketing and PR agency with a healthcare and technology practice. Comparable B2B healthcare communications services with similar mid-market positioning and senior-led engagement.
• Inizio Evoke: Global health communications and commercialization agency serving pharma, biotech, and consumer health clients. Direct competitor in the healthcare PR and strategic communications space with overlapping service offerings (PR, IR, digital, creative).
• ICR (Healthcare): Healthcare-focused strategic communications and investor relations firm. Direct competitor for biotech IR, IPO communications, and corporate positioning with overlapping senior-led engagement model.
• Westwicke: Healthcare-focused investor relations and strategic communications firm (now part of ICR). Competes for the same biotech and medtech IR engagements, particularly for emerging and mid-cap healthcare companies.

Broad incumbents

• APCO Worldwide (Health): Global advisory and communications firm with healthcare and public health practices. Competes for government/public health and pharma communications with significantly broader geographic reach and policy depth.
• Weber Shandwick (Health): Global PR network with a substantial health practice serving pharmaceutical, biotech, and public health organizations. Competes for enterprise healthcare communications at much larger scale and global footprint.
• Edelman (Health): Global communications firm with a dedicated health practice serving pharma, biotech, consumer health, and public health clients. Larger, broader portfolio incumbent competing for the same healthcare accounts at greater scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/lavoiegroup
• Facebookfacebook.com/LaVoieGroup
• LinkedInlinkedin.com/company/lavoie-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LaVoieHealthScience